$1.79
0.00500.28%
After Hours: 7:05 AM EDT
15 minutes delayed
Chemomab Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Chemomab Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-09 | $-0.34 | $-0.02 | -1600.0 % |
Jun 2023 | 2023-08-14 | $-0.72 | $-0.80 | 10.0 % |
Mar 2023 | 2023-05-11 | $-0.80 | $-0.03 | -2566.7 % |
Sep 2022 | 2022-11-11 | $-0.70 | $-0.33 | -112.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Chemomab Therapeutics (CMMB) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 21, 2024 for Q2.
The Actual EPS was $-0.26, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.